Bruker Lowers FY2025 Adj EPS Guidance from $1.95-$2.05 to $1.85-$1.90 vs $1.96 Est; Lowers FY2025 Sales Guidance from $3.430B-$3.500B to $3.410B-$3.440B vs $3.441B Est
Author: Benzinga Newsdesk | November 03, 2025 07:02am
Bruker (NASDAQ:
BRKR) lowers FY2025 Adj EPS guidance from $1.95-$2.05 to $1.85-$1.90 vs $1.96 analyst estimate. Lowers FY2025 sales outlook from $3.430 billion-$3.500 billion to $3.410 billion-$3.440 billion vs $3.441 billion estimate.
Posted In: BRKR